INTOCELL
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
INTOCELL
Industry:
Biotechnology Information Technology Medical
Founded:
2015-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.intocell.co.kr
Total Employee:
11+
Status:
Active
Total Funding:
1000 M KRW
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Nginx Euro Google Maps PHP PHP 7
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Stonebridge Capital
Stonebridge Capital investment in Series A - Intocell
Official Site Inspections
http://www.intocell.co.kr
- Host name: 121.254.178.235
- IP address: 121.254.178.235
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Intocell"
Intocell
์ฌ์ดํธ ์ ๋ณด. COMPANY : INTOCELL CEO : Tae-Kyo Park ADDRESS : 101, Sinildong-ro, Daedeok-gu, Daejeon, Republic of Korea TEL : +82 - 042 - 716 - 0083 FAX : +82 - 042 - 716 - โฆSee details»
Intocell - Crunchbase Company Profile & Funding
Organization. Intocell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Intocell is a biotechnology company that โฆSee details»
IntoCell Company Profile 2025: Valuation, Funding & Investors
IntoCell General Information Description. Operator of a biotechnology company intended to develop a novel antibody-drug conjugate (ADC) for patients. The company technologies offers โฆSee details»
IntoCell, - ์ธํฌ์
IntoCell, Into Global Biotech. Global bio-Technology Giant๋ฅผ ๋ชฉํ๋ก ํญ์ ...See details»
IntoCell, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IntoCell, Inc. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet.See details»
์ธํฌ์ - ์ํค๋ฐฑ๊ณผ, ์ฐ๋ฆฌ ๋ชจ๋์ ๋ฐฑ๊ณผ์ฌ์
์ธํฌ์ (Intocell)์ ๋ํ๋ฏผ๊ตญ์ ADC ํ๋ซํผ ์ฐ๊ตฌ๊ฐ๋ฐ ๊ธฐ์ ์ด๋ค. [1] ๋ณธ์ฌ๋ ๋์ ๊ด์ญ์ ๋๋๊ตฌ ์ ์ผ๋๋ก 101 (์ ์ผ๋)์ ์์นํด ์์ผ๋ฉฐ ๋ํ์ด์ฌ๋ ๋ฐํ๊ต์ด๋ค. [2]See details»
IntoCell Inc - LinkedIn
IntoCell Inc Biotechnology Research Biotechnology company developing antiCancer drug (ADC/ISAC) at Daejeon, South KoreaSee details»
IntoCell Company Profile | Management and Employees List
IntoCell Profile and History. IntoCell is a Korea-based biotechnology company dedicated to the development and commercialisation of novel ADC platform technologies comprising scaffold โฆSee details»
IntoCell, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types โฆSee details»
IntoCell - Overview, News & Similar companies | ZoomInfo.com
SHANGHAI, Jan. 3, 2024 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types โฆSee details»
CEO ์ธ์ฌ๋ง | ์ธํฌ์ - intocell.com
์ ๊ทํ ์ ์ฝ๊ฐ๋ฐ ๊ธฐ๋ฐ๊ธฐ์ ํ๋ณด global biotech. ์ธํฌ์ ์ ์ธ๊ณ์ ์ผ๋ก ์ ๊ทํ ์ ์ฝ๊ฐ๋ฐ ๊ธฐ๋ฐ๊ธฐ์ ํ๋ณด๋ฅผ ๋ชฉํ๋ก, ๊ตฌ์ฒด์ ์ด๊ณ ์ค์ฆ์ ์ธ ์ฐ๊ตฌ๊ฐ๋ฐ์ ํตํด ๋ ์ฐฝ์ ์ธ ์์ด๋์ด์ ๊ฐ๋ ์ฆ๋ช ์ โฆSee details»
WuXi XDC Enters into Partnership Agreement with IntoCell, โฆ
SHANGHAI, Jan 3, 2024โWuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate โฆSee details»
IntoCell Company Profile - Office Locations, Competitors ... - Craft
IntoCell is a company that develops and commercializes conjugate platform technologies, comprised of scaffold moiety, ligands, toxins, linkers, and conjugation methods. It aims to help โฆSee details»
IntoCell, Inc. (IntoCell, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆ โฆ
SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types โฆSee details»
Intocell Inc. - BioCentury Company Profiles - BCIQ
May 14, 2024 Intocell Inc. - BioCentury Company Profiles for the biopharma industrySee details»
WuXi XDC Enters into Partnership Agreement with IntoCell, โฆ
Jan 3, 2024 WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market, and โฆSee details»
Intocell - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Intocell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board โฆSee details»
Intocell - Funding, Financials, Valuation & Investors - Crunchbase
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How โฆSee details»
WuXi XDC Enters Into Partnership Agreement With IntoCell, โฆ
Shanghai /PRNewswire/ - WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate โฆSee details»
WuXi CRDMO spinoff WuXi XDC inks partnership with IntoCell
Jan 3, 2024 WuXi Biologics WuXi STA contract research organization partnership WuXi XDC, which spun off from WuXi Bio And WuXi STA in November, has forged a partnership with the โฆSee details»